Allianz Asset Management’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74,000
| Closed | -$297K | – | 1590 |
|
|
2025
Q1 | $297K | Buy |
74,000
+23,300
| +46% | +$93.4K | ﹤0.01% | 1577 |
|
|
2024
Q4 | $329K | Buy |
50,700
+13,300
| +36% | +$86.3K | ﹤0.01% | 1512 |
|
|
2024
Q3 | $207K | Hold |
37,400
| – | – | ﹤0.01% | 1614 |
|
|
2024
Q2 | $209K | Buy |
+37,400
| New | +$209K | ﹤0.01% | 1561 |
|
|
2022
Q3 | – | Sell |
-30,415
| Closed | -$326K | – | 1491 |
|
|
2022
Q2 | $326K | Buy |
+30,415
| New | +$326K | ﹤0.01% | 1728 |
|